nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—Parathyroid disorder—Riluzole—amyotrophic lateral sclerosis	0.0981	0.213	CcSEcCtD
L-Carnitine—CES1—Phase I biotransformations, non P450—PON1—amyotrophic lateral sclerosis	0.0265	0.0917	CbGpPWpGaD
L-Carnitine—Choline—CHAT—amyotrophic lateral sclerosis	0.0218	1	CrCbGaD
L-Carnitine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.018	0.0391	CcSEcCtD
L-Carnitine—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0163	0.0353	CcSEcCtD
L-Carnitine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0146	0.0318	CcSEcCtD
L-Carnitine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0277	CcSEcCtD
L-Carnitine—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0244	CcSEcCtD
L-Carnitine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.011	0.024	CcSEcCtD
L-Carnitine—SLC25A29—medulla oblongata—amyotrophic lateral sclerosis	0.0107	0.047	CbGeAlD
L-Carnitine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0225	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.0101	0.035	CbGpPWpGaD
L-Carnitine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00991	0.0215	CcSEcCtD
L-Carnitine—SLC25A29—spinal cord—amyotrophic lateral sclerosis	0.00956	0.0419	CbGeAlD
L-Carnitine—Injury—Riluzole—amyotrophic lateral sclerosis	0.00893	0.0194	CcSEcCtD
L-Carnitine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00866	0.0188	CcSEcCtD
L-Carnitine—SLC25A20—medulla oblongata—amyotrophic lateral sclerosis	0.00855	0.0375	CbGeAlD
L-Carnitine—CRAT—medulla oblongata—amyotrophic lateral sclerosis	0.0083	0.0364	CbGeAlD
L-Carnitine—SLC25A29—nervous system—amyotrophic lateral sclerosis	0.00805	0.0353	CbGeAlD
L-Carnitine—SLC25A29—central nervous system—amyotrophic lateral sclerosis	0.00775	0.034	CbGeAlD
L-Carnitine—SLC25A20—spinal cord—amyotrophic lateral sclerosis	0.00763	0.0334	CbGeAlD
L-Carnitine—SLC25A29—cerebellum—amyotrophic lateral sclerosis	0.00758	0.0332	CbGeAlD
L-Carnitine—CRAT—spinal cord—amyotrophic lateral sclerosis	0.0074	0.0324	CbGeAlD
L-Carnitine—CROT—nervous system—amyotrophic lateral sclerosis	0.00739	0.0324	CbGeAlD
L-Carnitine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00726	0.0158	CcSEcCtD
L-Carnitine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00724	0.0157	CcSEcCtD
L-Carnitine—CROT—central nervous system—amyotrophic lateral sclerosis	0.00711	0.0312	CbGeAlD
L-Carnitine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00709	0.0154	CcSEcCtD
L-Carnitine—CROT—cerebellum—amyotrophic lateral sclerosis	0.00695	0.0305	CbGeAlD
L-Carnitine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00682	0.0148	CcSEcCtD
L-Carnitine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00645	0.014	CcSEcCtD
L-Carnitine—XDH—Oxidative Stress—GSR—amyotrophic lateral sclerosis	0.00643	0.0222	CbGpPWpGaD
L-Carnitine—SLC25A20—nervous system—amyotrophic lateral sclerosis	0.00643	0.0282	CbGeAlD
L-Carnitine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00642	0.0139	CcSEcCtD
L-Carnitine—CPT2—medulla oblongata—amyotrophic lateral sclerosis	0.00638	0.028	CbGeAlD
L-Carnitine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00631	0.0137	CcSEcCtD
L-Carnitine—CRAT—nervous system—amyotrophic lateral sclerosis	0.00623	0.0273	CbGeAlD
L-Carnitine—SLC25A20—central nervous system—amyotrophic lateral sclerosis	0.00619	0.0271	CbGeAlD
L-Carnitine—SLC25A29—brain—amyotrophic lateral sclerosis	0.00616	0.027	CbGeAlD
L-Carnitine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00615	0.0133	CcSEcCtD
L-Carnitine—SLC25A20—cerebellum—amyotrophic lateral sclerosis	0.00605	0.0265	CbGeAlD
L-Carnitine—CRAT—central nervous system—amyotrophic lateral sclerosis	0.006	0.0263	CbGeAlD
L-Carnitine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00593	0.0129	CcSEcCtD
L-Carnitine—CRAT—cerebellum—amyotrophic lateral sclerosis	0.00587	0.0257	CbGeAlD
L-Carnitine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0124	CcSEcCtD
L-Carnitine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00569	0.0124	CcSEcCtD
L-Carnitine—CPT2—spinal cord—amyotrophic lateral sclerosis	0.00569	0.0249	CbGeAlD
L-Carnitine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00568	0.0123	CcSEcCtD
L-Carnitine—CROT—brain—amyotrophic lateral sclerosis	0.00565	0.0247	CbGeAlD
L-Carnitine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0122	CcSEcCtD
L-Carnitine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00559	0.0121	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00553	0.0191	CbGpPWpGaD
L-Carnitine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00531	0.0115	CcSEcCtD
L-Carnitine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00515	0.0112	CcSEcCtD
L-Carnitine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00507	0.011	CcSEcCtD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00507	0.0175	CbGpPWpGaD
L-Carnitine—SLC25A20—brain—amyotrophic lateral sclerosis	0.00491	0.0215	CbGeAlD
L-Carnitine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00484	0.0105	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0048	0.0166	CbGpPWpGaD
L-Carnitine—CPT2—nervous system—amyotrophic lateral sclerosis	0.0048	0.021	CbGeAlD
L-Carnitine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0104	CcSEcCtD
L-Carnitine—CRAT—brain—amyotrophic lateral sclerosis	0.00477	0.0209	CbGeAlD
L-Carnitine—CPT1A—cerebellum—amyotrophic lateral sclerosis	0.00476	0.0208	CbGeAlD
L-Carnitine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0103	CcSEcCtD
L-Carnitine—CPT2—central nervous system—amyotrophic lateral sclerosis	0.00462	0.0202	CbGeAlD
L-Carnitine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00992	CcSEcCtD
L-Carnitine—CPT2—cerebellum—amyotrophic lateral sclerosis	0.00451	0.0198	CbGeAlD
L-Carnitine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00964	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00439	0.0152	CbGpPWpGaD
L-Carnitine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00948	CcSEcCtD
L-Carnitine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00936	CcSEcCtD
L-Carnitine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0093	CcSEcCtD
L-Carnitine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00926	CcSEcCtD
L-Carnitine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00914	CcSEcCtD
L-Carnitine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00914	CcSEcCtD
L-Carnitine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00419	0.0091	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00408	0.0141	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00408	0.0141	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00408	0.0141	CbGpPWpGaD
L-Carnitine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0087	CcSEcCtD
L-Carnitine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00855	CcSEcCtD
L-Carnitine—CPT1A—brain—amyotrophic lateral sclerosis	0.00386	0.0169	CbGeAlD
L-Carnitine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00835	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00384	0.0133	CbGpPWpGaD
L-Carnitine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00818	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00373	0.0129	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00373	0.0129	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00798	CcSEcCtD
L-Carnitine—CPT2—brain—amyotrophic lateral sclerosis	0.00367	0.0161	CbGeAlD
L-Carnitine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00792	CcSEcCtD
L-Carnitine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00786	CcSEcCtD
L-Carnitine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00781	CcSEcCtD
L-Carnitine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00771	CcSEcCtD
L-Carnitine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00761	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00756	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00347	0.012	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00347	0.012	CbGpPWpGaD
L-Carnitine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00749	CcSEcCtD
L-Carnitine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00749	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00331	0.0114	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00716	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00326	0.0113	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00326	0.0113	CbGpPWpGaD
L-Carnitine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00692	CcSEcCtD
L-Carnitine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00692	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00311	0.0107	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00304	0.0105	CbGpPWpGaD
L-Carnitine—XDH—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00299	0.0103	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00645	CcSEcCtD
L-Carnitine—XDH—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	0.00291	0.01	CbGpPWpGaD
L-Carnitine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00628	CcSEcCtD
L-Carnitine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0062	CcSEcCtD
L-Carnitine—CES1—nervous system—amyotrophic lateral sclerosis	0.00285	0.0125	CbGeAlD
L-Carnitine—MPO—spinal cord—amyotrophic lateral sclerosis	0.00282	0.0124	CbGeAlD
L-Carnitine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00599	CcSEcCtD
L-Carnitine—CES1—central nervous system—amyotrophic lateral sclerosis	0.00274	0.012	CbGeAlD
L-Carnitine—XDH—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00272	0.00939	CbGpPWpGaD
L-Carnitine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00579	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00263	0.00908	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00263	0.00908	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00259	0.00893	CbGpPWpGaD
L-Carnitine—SLC22A4—spinal cord—amyotrophic lateral sclerosis	0.00258	0.0113	CbGeAlD
L-Carnitine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00557	CcSEcCtD
L-Carnitine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00552	CcSEcCtD
L-Carnitine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00552	CcSEcCtD
L-Carnitine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00549	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00241	0.00831	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0024	0.00828	CbGpPWpGaD
L-Carnitine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0052	CcSEcCtD
L-Carnitine—MPO—nervous system—amyotrophic lateral sclerosis	0.00238	0.0104	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.0023	0.00796	CbGpPWpGaD
L-Carnitine—MPO—central nervous system—amyotrophic lateral sclerosis	0.00229	0.01	CbGeAlD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00224	0.00772	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00224	0.00772	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00224	0.00772	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00223	0.00771	CbGpPWpGaD
L-Carnitine—CES1—brain—amyotrophic lateral sclerosis	0.00218	0.00954	CbGeAlD
L-Carnitine—MPO—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00218	0.00751	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00214	0.00738	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00214	0.00738	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00213	0.00736	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00213	0.00736	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00213	0.00736	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.0021	0.00726	CbGpPWpGaD
L-Carnitine—SLC22A4—cerebellum—amyotrophic lateral sclerosis	0.00204	0.00896	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00199	0.00688	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00196	0.00675	CbGpPWpGaD
L-Carnitine—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00191	0.00838	CbGeAlD
L-Carnitine—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.0019	0.00833	CbGeAlD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00188	0.00648	CbGpPWpGaD
L-Carnitine—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00183	0.00802	CbGeAlD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00182	0.0063	CbGpPWpGaD
L-Carnitine—MPO—brain—amyotrophic lateral sclerosis	0.00182	0.00797	CbGeAlD
L-Carnitine—CRAT—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00182	0.00628	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00182	0.00628	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00182	0.00628	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00182	0.00628	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00182	0.00628	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00177	0.00611	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00171	0.0059	CbGpPWpGaD
L-Carnitine—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.00171	0.00748	CbGeAlD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00169	0.00585	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00169	0.00585	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00167	0.00576	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00166	0.00574	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00166	0.00574	CbGpPWpGaD
L-Carnitine—SLC22A4—brain—amyotrophic lateral sclerosis	0.00166	0.00728	CbGeAlD
L-Carnitine—CES1—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00163	0.00564	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.00161	0.00555	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00155	0.00535	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00155	0.00534	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00155	0.00534	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—DAO—amyotrophic lateral sclerosis	0.00155	0.00534	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00154	0.00534	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00147	0.00507	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00146	0.00503	CbGpPWpGaD
L-Carnitine—SLC22A8—brain—amyotrophic lateral sclerosis	0.00145	0.00637	CbGeAlD
L-Carnitine—SLC25A20—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00145	0.00502	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00145	0.00502	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00144	0.00498	CbGpPWpGaD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00141	0.00487	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00141	0.00486	CbGpPWpGaD
L-Carnitine—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.00135	0.00593	CbGeAlD
L-Carnitine—CRAT—Metabolism—DAO—amyotrophic lateral sclerosis	0.00131	0.00454	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—DAO—amyotrophic lateral sclerosis	0.00131	0.00454	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00131	0.00454	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00131	0.00454	CbGpPWpGaD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00128	0.00441	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00126	0.00435	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00123	0.00425	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00117	0.00405	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00117	0.00405	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00117	0.00405	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00117	0.00404	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00113	0.00389	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.0011	0.00381	CbGpPWpGaD
L-Carnitine—SLC22A5—brain—amyotrophic lateral sclerosis	0.0011	0.00482	CbGeAlD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00109	0.00377	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSR—amyotrophic lateral sclerosis	0.00108	0.00373	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00107	0.0037	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000999	0.00345	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000998	0.00345	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000996	0.00344	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000996	0.00344	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000996	0.00344	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000985	0.0034	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000984	0.0034	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000957	0.0033	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000936	0.00323	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSR—amyotrophic lateral sclerosis	0.000919	0.00317	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSR—amyotrophic lateral sclerosis	0.000919	0.00317	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000888	0.00307	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000887	0.00306	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000853	0.00295	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000847	0.00292	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000846	0.00292	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000837	0.00289	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000837	0.00289	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000812	0.0028	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000812	0.0028	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00081	0.0028	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000765	0.00264	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000757	0.00261	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000755	0.00261	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000755	0.00261	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000743	0.00256	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000738	0.00255	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000719	0.00248	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000711	0.00246	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00069	0.00238	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000689	0.00238	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000689	0.00238	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000678	0.00234	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000667	0.0023	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00065	0.00225	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000649	0.00224	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000642	0.00222	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000641	0.00221	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000636	0.0022	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000622	0.00215	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000603	0.00208	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000592	0.00205	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000587	0.00203	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000581	0.00201	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000581	0.00201	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00058	0.002	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000572	0.00197	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000555	0.00192	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000551	0.0019	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00054	0.00187	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000539	0.00186	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000538	0.00186	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000538	0.00186	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000533	0.00184	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000508	0.00175	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000494	0.00171	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000492	0.0017	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000486	0.00168	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000486	0.00168	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000486	0.00168	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000477	0.00165	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000472	0.00163	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000472	0.00163	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000467	0.00161	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000458	0.00158	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000457	0.00158	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000445	0.00154	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000444	0.00153	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00044	0.00152	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000438	0.00151	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000433	0.0015	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00043	0.00148	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00043	0.00148	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000411	0.00142	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000406	0.0014	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000406	0.0014	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—DAO—amyotrophic lateral sclerosis	0.000389	0.00134	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000389	0.00134	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000374	0.00129	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000373	0.00129	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000373	0.00129	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000365	0.00126	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000365	0.00126	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—APOE—amyotrophic lateral sclerosis	0.000361	0.00125	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000348	0.0012	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000337	0.00116	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00033	0.00114	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00033	0.00114	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000326	0.00112	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000308	0.00106	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—APOE—amyotrophic lateral sclerosis	0.000307	0.00106	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—APOE—amyotrophic lateral sclerosis	0.000307	0.00106	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000304	0.00105	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000295	0.00102	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000295	0.00102	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000295	0.00102	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000288	0.000996	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000283	0.000978	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000283	0.000978	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSR—amyotrophic lateral sclerosis	0.000272	0.000939	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000264	0.000911	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000261	0.000903	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000259	0.000894	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000251	0.000867	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000251	0.000867	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000247	0.000854	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000241	0.000831	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00024	0.00083	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000226	0.000782	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000224	0.000772	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000223	0.000771	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000211	0.000728	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00021	0.000726	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00021	0.000726	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000205	0.000707	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000198	0.000683	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000181	0.000626	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000167	0.000575	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000155	0.000536	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000143	0.000494	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000137	0.000473	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000135	0.000468	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00013	0.00045	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00012	0.000415	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000118	0.000406	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00011	0.000381	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000107	0.00037	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.39e-05	0.000324	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOE—amyotrophic lateral sclerosis	9.07e-05	0.000313	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.35e-05	0.000254	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.32e-05	0.000218	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.22e-05	0.000215	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.8e-05	0.0002	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	4.78e-05	0.000165	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.27e-05	0.000113	CbGpPWpGaD
